71541Medstar Georgetown University Medical Center, Pulmonary, Critical Care and Sleep Medicine, Washington DC, 20007.
12230Georgetown University School of Medicine, Medical Dental Building, 3900 Reservoir Road, NW, Washington DC, 2007.
J Intensive Care Med. 2022 Jul;37(7):883-889. doi: 10.1177/08850666221081757. Epub 2022 Feb 23.
Prone positioning is widely used in mechanically ventilated patients with COVID-19; however, the specific clinical scenario in which the individual is most poised to benefit is not fully established. In patients with COVID-19 respiratory failure requiring mechanical ventilation, how effective is prone positioning in improving oxygenation and can that response be predicted?
This is a retrospective observational study from two tertiary care centers including consecutive patients mechanically ventilated for COVID-19 from 3/1/2020 - 7/1/2021. The primary outcome is improvement in oxygenation as measured by PaO/FiO. We describe oxygenation before, during and after prone episodes with a focus on identifying patient, respiratory or ventilator variables that predict prone positioning success.
2 Tertiary Care Academic Hospitals.
125 patients mechanically ventilated for COVID-19 respiratory failure.
Prone positioning.
One hundred twenty-five patients underwent prone positioning a total of 309 times for a median duration of 23 hours IQR (14 - 49). On average, PaO/FiO improved 19%: from 115 mm Hg (80 - 148) immediately before proning to 137 mm Hg (95 - 197) immediately after returning to the supine position. Prone episodes were more successful if the pre-prone PaO/FiO was lower and if the patient was on inhaled epoprostenol (iEpo). For individuals with severe acute respiratory distress syndrome (ARDS) (PaO/FiO < 100 prior to prone positioning) and on iEpo, the median improvement in PaO/FiO was 27% in both instances.
Prone positioning in mechanically ventilated patients with COVID-19 is generally associated with sustained improvements in oxygenation, which is made more likely by the concomitant use of iEpo and is more impactful in those who are more severely hypoxemic prior to prone positioning.
俯卧位被广泛应用于 COVID-19 机械通气患者;然而,尚未充分明确最适合个体受益的具体临床情况。对于需要机械通气的 COVID-19 呼吸衰竭患者,俯卧位通气在改善氧合方面的效果如何,这种反应能否预测?
这是一项来自两家三级护理中心的回顾性观察性研究,纳入了 2020 年 3 月 1 日至 2021 年 7 月 1 日期间因 COVID-19 接受机械通气的连续患者。主要结局是通过 PaO/FiO 评估的氧合改善。我们描述了俯卧位期间和之后的氧合情况,重点是确定预测俯卧位成功的患者、呼吸或通气机变量。
2 家三级护理学术医院。
125 例因 COVID-19 呼吸衰竭而接受机械通气的患者。
俯卧位通气。
125 例患者共进行了 309 次俯卧位通气,中位持续时间为 23 小时 IQR(14-49)。平均而言,PaO/FiO 提高了 19%:从俯卧位前的 115mmHg(80-148)提高到回到仰卧位后的 137mmHg(95-197)。如果俯卧位前的 PaO/FiO 较低且患者正在使用吸入性前列环素(iEpo),则俯卧位通气的效果更好。对于患有严重急性呼吸窘迫综合征(ARDS)(俯卧位前 PaO/FiO <100)且正在使用 iEpo 的个体,在这两种情况下,PaO/FiO 的中位数改善均为 27%。
对于 COVID-19 机械通气患者,俯卧位通气通常与氧合的持续改善相关,同时使用 iEpo 可增加这种改善的可能性,并且在俯卧位前氧合更严重不足的患者中效果更为显著。